Gnanapragasam, VJ, Hori, S, Johnston, T, Smith, D, Muir, K, Alonzi, R, Winkler, M, Warren, A, Staffurth, John ![]() ![]() |
Preview |
PDF
- Accepted Post-Print Version
Download (368kB) | Preview |
Abstract
The management of high-risk prostate cancer has become increasingly sophisticated, with refinements in radical therapy and the inclusion of adjuvant local and systemic therapies. Despite this, high-risk prostate cancer continues to have significant treatment failure rates, with progression to metastasis, castrate resistance and ultimately disease-specific death. In an effort to discuss the challenges in this field, the UK National Clinical Research Institute’s Prostate Cancer Clinical Studies localised subgroup convened a multidisciplinary national meeting in the autumn of 2014. The remit of the meeting was to debate and reach a consensus on the key clinical and research challenges in high-risk prostate cancer and to identify themes that the UK would be best placed to pursue to help improve outcomes. This report presents the outcome of those discussions and the key recommendations for future research in this highly heterogeneous disease entity.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Schools > Medicine |
Publisher: | Sage |
ISSN: | 2051-4158 |
Date of First Compliant Deposit: | 12 February 2018 |
Date of Acceptance: | 28 April 2016 |
Last Modified: | 23 May 2023 21:29 |
URI: | https://orca.cardiff.ac.uk/id/eprint/103671 |
Actions (repository staff only)
![]() |
Edit Item |